Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

One-Two Punch of Romosozumab, Denosumab Improved BMD and Reduced Fractures

AUSTIN, Texas – One year of romosozumab (Evenity) followed by 1 year of denosumab (Prolia, Xgeva) was associated with improved bone mineral density (BMD) and lower fracture incidence compared with 2 years of denosumab in women with osteoporosis, an analysis of the FRAME studies suggested. Treatment with romosozumab first was associated with a 16.8% increase […]

Heart Transplant: A Slightly More Level Playing Field Under New UNOS System

Recent changes to U.S. donor heart allocation were followed by a narrowing of racial disparities in listing and transplant, though much more work remains to eliminate inequality, researchers warned. Black patients listed for cardiac transplantation in 2011-2020 were less likely than white peers to die while waiting (adjusted HR 0.88, 95% CI 0.78-0.98). However, they […]

DBN Health News